Rehabilitation for long COVID-19 symptoms
Official title: Intervention Against Long COVID in Norway - Systematic Rehabilitation. A Randomised Pilot and Feasibility Study.
Run by University Hospital of North Norway · NCT06085911 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a rehabilitation program for people with long COVID-19 symptoms, especially those affecting their thinking and daily life, to see if it helps them feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University Hospital of North Norway Academic / other |
| Locations | 1 site (Tromsø, Troms) |
| Trial ID | NCT06085911 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 65 who exhibit symptoms of long COVID affecting their daily activities and have a positive COVID-19 test.
✕Probably not a fit
Patients with pre-existing chronic neurocognitive diseases or those unwilling to comply with study protocols may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial focuses on developing treatment interventions for individuals suffering from long COVID-19, particularly those experiencing neurocognitive symptoms that impact daily activities. Participants will undergo a one-day course followed by individual follow-ups to assess the effectiveness of the rehabilitation approach. The study aims to quantify the prevalence and underlying mechanisms of long COVID while addressing the significant burden it places on healthcare services. The trial is conducted in collaboration with several prominent Norwegian universities and hospitals.
Why it matters
Potential benefit: If successful, this study could provide effective rehabilitation strategies for patients suffering from long COVID, improving their quality of life and daily functioning.
How similar studies have gone: While there is ongoing research into long COVID rehabilitation, this specific approach is novel and aims to fill gaps in current knowledge and treatment strategies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Symptoms attributable to long COVID according to WHO definition \[14\] that affect their daily activities * Positive Covid test; a home-test, PCR test or serology. * Neurocognitive symptoms * Age between 18 and 65 years * Participant is able and willing to provide informed consent Exclusion Criteria: * Patients that do not want to comply to planned physical study visits * Patients who are unable to complete surveys in Norwegian * Patients with known chronic neurocognitive disease before Covid-19 or other diseases that can explain current symptoms
Where it's running
-
University hospital of North Norway
Tromsø, Troms, Norway Recruiting
Study contacts
- Principal investigator: Maja Wilhelmsen, ph.d — University Hospital of North Norway
- Study coordinator: Maja Wilhelmsen, MD, Ph.d
- Email: maja.wilhelmsen@unn.no
- Phone: +4777627834
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Second cohort following patients entering a multidisciplinary care pathway for post-COVID syndromes (SyPoCo2)
This project will test whether linking long COVID patients' symptoms with blood immune and molecular markers can find biomarkers and possible treatment targets.
-
Accelerated intermittent theta-burst stimulation for depression with post‑COVID‑19 condition
This will test whether two different schedules of intermittent theta-burst stimulation (accelerated TMS) reduce depressive symptoms and inflammation in adults aged 18–65 who have depressive disorder plus post‑COVID‑19 condition.
-
2-HOBA to reduce persistent immune activation in Long COVID with POTS
This trial will test whether 2‑HOBA, a compound that scavenges harmful IsoLG-adducts, can reduce immune activation in adults with Long COVID who have POTS.
-
Long COVID relief through learning mindfulness
This study will try an 8-week online recorded mindfulness program to see if it reduces stress and Long COVID symptoms in adults who continue their usual care.
-
Investigating dysfunctional breathing in patients with post COVID-19 condition
This study is trying to see how breathing problems affect people who are dealing with long-term symptoms after having COVID-19.
-
Evaluating Apabetalone for Long-COVID in Diabetes Patients
This study is testing if adding a new medication called Apabetalone to the diabetes drug dapagliflozin can help people with Type 2 Diabetes who are dealing with Long-COVID symptoms feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.